Navigation Links
Reportlinker Adds Pharmaceutical Management of Obesity (Technical Insights)
Date:5/19/2011

NEW YORK, May 19, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical Management of Obesity (Technical Insights)

http://www.reportlinker.com/p0503653/Pharmaceutical-Management-of-Obesity-Technical-Insights.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

The field of obesity management is seeing a lot of research and product development activities.This research service provides a detailed analysis of the technology developments and industry dynamics for obesity drugs. An evaluation of the adoption of obesity drugs has been discussed (regionwise) and some of the emerging areas of obesity research has also been highlighted. Some of the key industry drivers and challenges along with their market impact have been discussed.

Table of Contents

Executive Summary

Research Scope and Methodology 1

Research Scope and Segmentation1

Research Methodology 2

Research Overview 3

Introduction to Obesity and Anti-Obesity Drugs3

Key Findings and Analyst Insights 4

Technology Snapshot and Impact Analysis

Technology Snapshot 6

Anti-Obesity Drugs Classified on the Mode of Action6

Value Chain for Anti-Obesity Drugs 12

Assessment of Factors Influencing Adoption of Anti-Obesity Drugs 15

Market Impact of Key Drivers 15

Impact of Key Challenges and Restraints17

Regulatory Scenario 20

Diffusion of Innovations and Opportunity Evaluation

Diffusion of Innovation 23

Adoption of Anti-Obesity Drugs--North America 23

Adoption of Anti-Obesity Drugs--Europe and Asia Pacific 25

Overview of Partnerships and Alliances in the Industry 27

Opportunity Evaluation 31

Opportunity Strategy Evaluation of Anti-Obesity Drugs 31

Roadmap--Emerging Areas to Focus 34

Key Patents and Contacts

Key Patents 37

Issued Patents 37

Applied Patents40

Contacts 43

Corporate Contacts43

Academic Contacts44

D2A1 © 2011 Frost & Sullivan www frost com v

Pharmaceutical Management of Obesity

vi D2A1 © 2011 Frost & Sullivan www frost com

Decision Support Database

Decision Support Database Tables 46

Prevalence of Obese Population (2004-2014) 46

Pharmaceutical R&D Expenditure (2002-2012) 48

Total Healthcare Expenditure (2004-2014)50

To order this report:

Drug and Medication Industry: Pharmaceutical Management of Obesity (Technical Insights)

Drug and Medication Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Machine-to-Machine (M2M) Communications in Healthcare 2010-20
2. Reportlinker Adds Hong Kong SMBG Devices and Strips Market
3. Reportlinker Adds Medical Devices Reports Bundle
4. Reportlinker Adds Impact of Healthcare Reforms on the Medical Technology Industry
5. Reportlinker Adds Pharmaceuticals Reports Bundle
6. Reportlinker Adds North America Hospital Supplies Market Outlook to 2017
7. Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017
8. Reportlinker Adds Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
9. Reportlinker Adds Pharmaceutical Key Trends 2011 - Socio-Demographic and Economic Overview : Rising Healthcare Costs Coupled with the Economic Downturn Continue to Shape the Healthcare Landscape
10. Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
11. Reportlinker Adds Markets for Emerging Pharmaceutical Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):